Radiotherapy in multilocalized lymphedema-associated angiosarcoma

European Journal of Dermatology

Volumn 15, Issue 6, 2005, Pages 474-477

  Danz, Beate ^a   Hellmann, Andrea ^a   Stadie, Volker ^a   Dunst, Jürgen ^a   Richter, Christine ^a   Marsch, Wolfgang Ch ^a   Helmbold, Peter ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Interferon ; Lymphangiosarcoma; Lymphedema; Radiotherapy; Stewart Treves Syndrome

Indexed keywords

BETA INTERFERON; CD31 ANTIGEN; CD34 ANTIGEN; DESMOPLAKIN;

AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CLINICAL FEATURE; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; LYMPHANGIOSARCOMA; LYMPHEDEMA; MASTECTOMY; MEDICAL EXAMINATION; METASTASIS; RADIOIMMUNOTHERAPY; SOLID TUMOR; STEWART TREVES SYNDROME; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR CELL;

AGED; AGED, 80 AND OVER; FEMALE; HEMANGIOSARCOMA; HUMANS; LYMPHEDEMA; SKIN NEOPLASMS;

EID: 28244447645     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Stewart F, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. Cancer 1948; 1: 64-81.
2. Marsch WC. Angiosarkom bei chronischem Lymphödem der unteren Extremität. Angiosarcoma in chronic lymphedema of the lower extremity. Med Welt l980; 31: 585-7.
3. Marsch WC. Das Stewart-Treves-Syndrom: ein Hämangiosarkom bei chronischem Lymphödem. Ultrastrukturelle Analyse differenter klinischer Entwicklungsstadien. Stewart-Treves syndrome: hemangiosarcoma in chronic lymphedema. Ultrastructural analysis of various clinical developmental stages. Hautarzt 1987; 38: 82-7.
4. Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Myoui A, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 1996; 61: 170-6.
5. Sasaki R, Soejima T, Kishi K, Imajo Y, Hirota S, Kamikonya N, et al. Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome, Int J Radiat Oncol Biol Phys 2002; 52: 1032-40.
6. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-6.
7. Ebata N, Nodasaka Y, Sawa Y, Yamaoka Y, Makino S, Totsuka Y, et al. Desmoplakin as a specific marker of lymphatic vessels. Microvasc Res 2001 ; 61: 40-8.
8. Eggermont AM, de Wilt JH, ten Hagen TL. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 2003; 4: 429-37.
9. Hoekstra HJ, van Ginkel RJ. Hyperthermic isolated limb perfusion in the management of extremity sarcoma. Curr Opin Oncol 2003; 15: 300-3.
10. Aboulafia DM, Morris D, Henry D, Grossman RJ, Thommes J, Bundow D, et al. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial. Arch Dermatol 2003; 139: 178-86.
11. Bodsworth NJ, Bloch M, Bower M, Donnell D, Yocum R. Phase III vehiclecontrolled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDSrelated Kaposi's sarcoma. Am J Clin Dermatol 2001; 2: 77-87.
12. Ulrich J, Krause M, Brachmann A, Franke I, Gollnick H. Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation. J Eur Acad Dermatol Venereal 2000; 14: 412-5.
13. Ohguri T, Imada H, Nomoto S, Yahara K, Hisaoka M, Hashimoto H, et al. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 1446-53.
14. Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002; 47: 124-7.
15. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276: 1423-5.